MedTrace Logo

Anti-Inflammatory Effect of Tocotrienol Supplementation in Subjects With Moderately Elevated Inflammation

NCT03532763 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2018-08-29

No results posted yet for this study

Summary

The objective of this study is to address the anti-inflammatory effect of tocotrienol supplementation in subjects with moderately elevated inflammation.

It is hypothesized that 6 months supplementation of tocotrienols will reduce inflammatory markers of subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Tocotrienol-rich fraction

1 capsule to be taken twice daily after meals for 6 months. Each capsule contains: 200 mg Tocotrienol-rich fraction

DIETARY_SUPPLEMENT

Placebo

1 capsule to be taken twice daily after meals for 6 months. Each capsule contains: Palm olein

Sponsors & Collaborators

  • Malaysia Palm Oil Board

    lead OTHER_GOV

  • Universiti Putra Malaysia

    collaborator OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-19
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532763 on ClinicalTrials.gov